TRAW
Traws Pharma·NASDAQ
--
--(--)
--
--(--)
3.66 / 10
Netural
Fund flow is strong (7.32/10) with positive large and extra‑large investor inflows, though small and medium flows are negative. Analyst sentiment is bullish—100% Strong Buy—but based on a single analyst with a –41.7% historical return, creating mixed confidence.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-03
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of TRAW?
- TRAW holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.66/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
